This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.
In this, my last newsletter in 2024, I offer some thoughts on biotech in 2025.
I’m taking a two-week break, so look for me again on Jan. 9. I hope you all have a Happy Hanukkah and a Merry Christmas.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in